Jennifer L. Taylor-Cousar, MD, MSCS, ATSF
Dr. Taylor-Cousar is a tenured professor of adult and pediatric pulmonary medicine at National Jewish Health (NJH), where she serves as the Medical Director of Clinical Research Services, Immediate Past President of the Medical Staff, and is co-director of the Adult CF Program and Director of the CF Therapeutics Development Network (TDN) center. She received her undergraduate degree in human biology from Stanford University in 1993, and completed her doctorate in medicine in 1998, combined residency in internal medicine and pediatrics in 2002, and her combined fellowship in adult and pediatric pulmonary medicine in 2006 at Duke University Medical Center. She obtained her Master of Clinical Science from the University of Colorado in 2015.
She has been site primary investigator on more than 60 clinical studies, and national/global primary investigator on 5 clinical trials. She is an elected member of the American Society for Clinical Investigation (2020). Her investigator initiated research focuses on the development and evaluation of novel therapies for the treatment of CF, including the impact of new therapies on the sexual and reproductive health of people with CF. She is also investigating the etiology and treatment of bronchiectasis in non-human primates.
She serves on numerous local and national committees including as the adult care center representative on the Cystic Fibrosis Foundation’s (CFF) Board of Trustees, on the CFF’s Clinical Research Advisory Board, the CF TDN’s Clinical Research Executive Committee, as immediate past Chair of the CF TDN’s Sexual Health Reproduction and Gender Research (SHARING) Working Group and served as Co-Chair of the Health Equity Team Science (HETS) Award review committee. She also serves as the Chair of the American Thoracic Society (ATS) International Conference Committee and has served on as on the Scientific Grant Review and Respiratory Health Awards Comittees. She was a standing study section member for the National Heart, Lung and Blood Institute, National Institutes of Health Clinical Trials Review (CLTR) and serves on the NHBLI DSMB for Gene/Cell Therapies. She is an Associate Editor for the Journal of Cystic Fibrosis and a member of the International Advisory Board for Lancet Respiratory Medicine. She has co-chaired numerous sessions and given invited lectures at the ATS International Conference, and the North American, European, Irish, Israeli, Mexican, Spanish and Australian CF Conferences, as well as at regional CF and pulmonary conferences and national and international veterinary conferences. She is an active member of the Colorado Chapter CF Board and is the Adult Care Advisor for the CFF Board of Trustees.
S12.3- Safety of CFTR modulators in healthy controls and pregnant people with CF
Thursday, October 23, 2025
2:30 PM - 4:30 PM PDT
Saturday, October 25, 2025
2:30 PM - 3:45 PM PDT